Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Robert John Andrew Ryan is Director at Asp Isotopes. OQRO lists 2 transactions filed with the SEC under this name, the latest on Oct 1, 2026, each linked to the official Form 4.
Director
Disclosures on record
2
Companies involved
1
Robert John Andrew Ryan bought shares on the open market in 2024 and 2026.
Robert John Andrew Ryan reported 14 open-market purchases and 0 sales since 2024; purchases in 2 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | $62K2×2 trades | — |
| 2024 | $161K12×12 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
2 buys, median −28.8 pts vs S&P 500, beat it 0 of 2 times.
Average −28.8 pts vs S&P 500. Each buy is one disclosure of open-market purchases in one company on one filing date, filed Sep 30, 2026 to Oct 1, 2026, measured from the first close after the filing. No purchase has reached 90 days yet, so 30 days is shown. Past results, not a forecast.
2 purchases disclosed. $1,000 placed after each of the 2 purchases disclosed since 2025-11-14 would be worth $1.2K today ($2K put in); the same in the S&P 500 (SPY): $2K.
Not ranked: fewer than 10 purchases measured at 90 days. The middle of the 82 ranked insiders is −5.5 pts (median, against the S&P 500).
Equal weight counts every purchase once; by size counts it for its disclosed dollars. Both are measured from the first close after it was reported. Past results describe the past, not a forecast. How this is measured · Leaderboard
Asp IsotopesASPI
2 disclosures · Sep 2026 – Oct 2026 · 2 bought
Sep 30, 2026Bought~$40Kdisclosed Oct 1
DetailsOfficial recordSep 28, 2026Bought~$22Kdisclosed Sep 30
DetailsOfficial recordAs of the latest filing on , Robert John Andrew Ryan reported holding 675,222 shares of Asp Isotopes (ASPI), worth about $1.17M at the last close of $2 (Nov 13, 2026). In the last 12 months, Robert John Andrew Ryan bought $62K in 2 open-market purchases.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Asp Isotopes ASPI | 675,222 | 675K direct | $2 | $1.17M | Sep 30, 2026 |
Is this Robert John Andrew Ryan’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Sep 30, 2026, Robert John Andrew Ryan reported holding 675,222 shares of Asp Isotopes (ASPI). At the last close of $2 on Nov 13, 2026, that is about $1.17M. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Robert John Andrew Ryan reported 2 open-market purchases worth $62K, and no open-market sale. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Robert John Andrew Ryan bought shares on the open market in 2024 and 2026.
In SEC filings since 2024: the latest open-market purchase is from 2026; no open-market sale is on record.
Asp Isotopes (ASPI), from 2024 to 2026: 14 purchases and 0 sales.
Robert John Andrew Ryan reported 14 open-market purchases and 0 sales here, 2024 to 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.